EFPIA Newsletter 09 September 2021

19 Conversations | EFPIA's Podcast Series     Listen to the podcast   Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain, "From raw materials to patients’ arms – how are COVID-19 vaccines made?" Listen to hear their discussion on the challenge and how we're preparing for the future. Read more →

News     02 September 2021 Improving Central and Eastern Europe health systems’ resilience and outcomes through higher... A new report highlights the need for increased healthcare spending in CEE countries and explores ways to increase efficiency... Read more →

Catch up with EFPIA's recent events

	How can COVID-19 treatments help us on the road to recovery? While vaccination programmes continue to scale up around the world, therapeutics play a key role in saving lives, freeing up capacity in intensive care units and treating patients living with long-COVID.		AMR: how can we prevent the next pandemic? While the COVID-19 pandemic caught the world by surprise, AMR is a predictable and preventable crisis and we have a critical opportunity to get ahead of it.

Upcoming events     14 SEP 2021   Building an Attractive Environment for Clinical Research in Turkey Virtual event Jointly organised by AIFD and EFPIA. Learn more →       23 SEP 2021   INNODIA & INNODIA HARVEST webinar Virtual event Arresting type 1 diabetes in Europe Learn more →

	24 SEP 2021			Health Systems after COVID-19 - how can the industry contribute to strengthened resilience?... Virtual event In the effort to making health systems more resilient to future pandemics and other shocks, both public institutions... Learn more →

	27 SEP 2021			Launch of the European Alliance for Cardiovascular Health Virtual event Save the Date Learn more →

	04 OCT 2021			How can we close the East-West healthcare investment gap in Europe? Virtual event Public healthcare spending in CEE countries has grown over time, but at a slower pace than GDP growth and today the... Learn more →

	14 OCT 2021			Accelerating Global Deletion of the Abnormal Toxicity Test. Planning common next... Virtual event Organised by AFSA/HSI and EFPIA in collaboration with IABS, the workshop aimed to assess the lingering barriers, to... Learn more →

What we published Healthcare outcomes and expenditure in Central and Eastern Europe – a review 02 September 2021 (Publications) Improving Central and Eastern Europe health systems’ resilience and outcomes through higher and more efficient healthcare... Read more → Addressing unmet needs in extremely rare and paediatric-onset diseases: how the biopharmaceutical... 28 July 2021 (Publications) A report by Dolon Read more → Health systems after COVID-19 15 July 2021 (Publications) A perspective on the future of European health systems Read more →

What we are reading EURORDIS Black Pearl Awards 2022 09 September 2021  (EURORDIS) Read more → Health systems after COVID-19 – Building resilience through a value-based approach 18 August 2021  (European Alliance for Value in Health) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe